blc2001: erdafitinib for muc
Published 4 years ago • 159 plays • Length 3:26Download video MP4
Download video MP3
Similar videos
-
1:49
blc2001: erdafitinib for the treatment of metastatic urothelial carcinoma
-
2:20
erdafitinib /- cetrelimab in muc patients with fgfr alterations
-
3:42
norse: erdafitinib cetrelimab in muc with fgfr alterations
-
2:12
erdafitinib: one more tool for bladder cancer
-
4:43
erdafitinib for fgfr-mutated urothelial carcinoma
-
2:31
an update on erdafitinib for metastatic/uresectable fgfr alteration urothelial carcinoma
-
1:04
thor: erdafitinib in advanced or metastatic urothelial cancer and fgfr alterations
-
1:28
erdafitinib for bladder cancer: more to come following fda approval
-
11:04
bladder cancer - overview (types, pathophysiology, diagnosis, treatment)
-
6:49
urothelial carcinoma - urinary system pathology
-
4:31
living the best life possible with metastatic bladder cancer
-
1:27
erdafitinib and enfortumab vedotin in pretreated fgfr2/3-mutant bladder cancer
-
0:49
evolving landscape of urothelial cancer treatment: erdafitinib or enfortumab vedotin?
-
0:16
imvigor 210 results in metastatic urothelial carcinoma
-
1:33
dr. balar on results of durvalumab plus tremelimumab in bladder cancer
-
1:27
thor-2 cohort 3 interim analysis: erdafitinib in intermediate-risk nmibc with fgfr3/2 alterations
-
1:11
dr. mayer fishman on new a treatment for patients with metastatic chemo-refractory urothelial cancer
-
1:05
what is a multidisciplinary bladder cancer clinic?
-
2:05
the evolving treatment landscape of advanced and metastatic urothelial carcinoma
-
1:19
dr. boorjian on research with nadofaragene firadenovec in nonmuscle invasive bladder cancer
-
0:46
molecular markers guiding treatment approaches in bladder cancer
-
3:37
phase iii thor study: erdafitinib vs. pembrolizumab in fgfr-altered advanced or metastatic uc